Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice

This publication has 21 references indexed in Scilit:

• Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm
  Behavioural Pharmacology, 2004
• Cannabinoid pharmacological properties common to other centrally acting drugs
  European Journal of Pharmacology, 2003
• (R)-Methanandamide and Δ9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A
  European Journal of Pharmacology, 2003
• Interactions between the CB1 receptor agonist Δ9-THC and the CB1 receptor antagonist SR-141716 in rats: Open-field revisited
  Pharmacology Biochemistry and Behavior, 2002
• Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition.
  2000
• In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity.
  1996
• Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys.
  1995
• Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212.
  1994
• Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol.
  1992
• Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs
  Pharmacology Biochemistry and Behavior, 1991